BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3501400)

  • 1. Interleukin-3 production as a sensitive measure of T-lymphocyte activation in the mouse.
    Dotsika EN; Sanderson CJ
    Immunology; 1987 Dec; 62(4):665-8. PubMed ID: 3501400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of a fibroblast-stimulating factor by Schistosoma mansoni antigen-reactive T cell clones.
    Lammie PJ; Michael AI; Linette GP; Phillips SM
    J Immunol; 1986 Feb; 136(3):1100-6. PubMed ID: 3510253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quantitative production of interferon by mitogen-stimulated mouse lymphocytes as a function of age and its effect on the lymphocytes proliferative response.
    Heine JW; Adler WH
    J Immunol; 1977 Apr; 118(4):1366-9. PubMed ID: 300406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.
    Metwali A; Blum A; Mathew R; Sandor M; Lynch RG; Weinstock JV
    Cell Immunol; 1993 Jun; 149(1):11-23. PubMed ID: 8099848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allo-Ia reactive murine T-cell lines. II. Mechanisms of clonal expansion of T cells explored by use of the allo-Ia reactive T cell clones.
    Narimatsu H; Saito K
    J Immunol; 1983 Jul; 131(1):37-44. PubMed ID: 6190916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of colony-stimulating factor production by murine T-lymphocyte clones.
    Kelso A; Metcalf D
    Exp Hematol; 1985 Jan; 13(1):7-15. PubMed ID: 3871704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell--vascular smooth muscle cell interactions: antigen-specific activation and cell cycle blockade of T helper clones by cloned vascular smooth muscle cells.
    Suttles J; Miller RW; Moyer CF
    Exp Cell Res; 1995 May; 218(1):331-8. PubMed ID: 7737369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte activation. V. Quantitation of the proliferative responses to mitogens using defined T and B cell populations.
    Janossy G; Greaves MF; Doenhoff MJ; Snajdr J
    Clin Exp Immunol; 1973 Aug; 14(4):581-96. PubMed ID: 4583779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
    Peterson LB; Wilner GD; Thomas DW
    J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones.
    Hecht TT; Longo DL; Matis LA
    J Immunol; 1983 Sep; 131(3):1049-55. PubMed ID: 6193170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 enhances long-term survival of CD28-deficient T cells.
    Stack RM; Thompson CB; Fitch FW
    J Immunol; 1998 Mar; 160(5):2255-62. PubMed ID: 9498765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic analysis of T-lymphocyte function in relation to hepatopathologic changes and effect of interleukin-12 treatment in mice infected with Schistosoma japonicum.
    Yang JQ; Tasaka K; Chuang CK; Yoshikawa H; Nakajima Y
    J Parasitol; 1999 Apr; 85(2):257-62. PubMed ID: 10219305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enumeration of IL 2-secreting helper T cells by limiting dilution analysis, and demonstration of unexpectedly high levels of IL 2 production per responding cell.
    Miller RA; Stutman O
    J Immunol; 1982 May; 128(5):2258-64. PubMed ID: 6977590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte activation. VI. A re-evaluation of factors affecting the selectivity of polyclonal mitogens for mouse T and B cells.
    Doenhoff MJ; Janossy G; Greaves MF; Gomer KJ; Snajdr J
    Clin Exp Immunol; 1974 Jul; 17(3):475-90. PubMed ID: 4549690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proliferation response of T lymphocytes to alloantigens in irradiated mice: a mixed lymphocyte reaction in vivo.
    Sprent J
    Transplant Proc; 1973 Dec; 5(4):1725-9. PubMed ID: 4272828
    [No Abstract]   [Full Text] [Related]  

  • 17. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.
    Srinivasan S; Bolick DT; Lukashev D; Lappas C; Sitkovsky M; Lynch KR; Hedrick CC
    Diabetes; 2008 Feb; 57(2):484-93. PubMed ID: 18003758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation by prostaglandin E2 of interleukin release by T lymphocytes in mucosa.
    Barrera S; Lai J; Fiocchi C; Roche JK
    J Cell Physiol; 1996 Jan; 166(1):130-7. PubMed ID: 8557762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human-mouse T-cell hybridoma-derived lymphokine inhibits thymidine uptake of T-lymphocytes.
    Laus R; Müller-Ruchholtz W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):96-7. PubMed ID: 2784914
    [No Abstract]   [Full Text] [Related]  

  • 20. Endotoxin-induced T lymphocyte proliferation.
    Vogel SN; Hilfiker ML; Caulfield MJ
    J Immunol; 1983 Apr; 130(4):1774-9. PubMed ID: 6601137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.